CASTLE BIOSCIENCES INC (CSTL)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Net revenues | 86,188 | 87,988 | 85,782 | 87,002 |
| Selling, general and administrative | 58,065 | 58,620 | 50,499 | 51,088 |
| Research and development | 12,787 | 12,588 | 12,323 | 14,136 |
| Cost of sales (exclusive of amortization of acquired intangible assets) | 17,626 | 16,383 | 15,609 | 14,519 |
| Amortization of acquired intangible assets | 1,961 | 28,325 | 2,272 | 2,247 |
| Total operating expenses, net | 90,439 | 115,916 | 80,703 | 81,990 |
| Operating (loss) income | -4,251 | -27,928 | 5,079 | 5,012 |
| Interest income | 2,944 | 3,099 | 3,404 | 3,144 |
| Interest expense | 21 | 17 | 201 | 270 |
| Changes in fair value of trading securities | 1,185 | -1,425 | - | - |
| (loss) income before income taxes | -143 | -26,271 | 8,282 | 7,886 |
| Income tax benefit | -4,666 | -423 | 6,013 | -1,034 |
| Net income (loss) | 4,523 | -25,848 | 2,269 | 8,920 |
| Basic (in dollars per share) | 0.16 | -0.9 | 0.08 | 0.32 |
| Basic (in shares) | 28,914,000 | 28,609,000 | 27,840,000 | 27,646,000 |
| Diluted (in dollars per share) | 0.15 | -0.9 | 0.08 | 0.31 |
| Diluted (in shares) | 29,545,000 | 28,609,000 | 29,401,000 | 28,738,000 |